レノックス・ガストー症候群治療薬の世界市場（～2026年）

• 英文タイトル：Global Lennox-Gastaut Syndrome Drug Market Insights and Forecast to 2026

• レポートコード：MRC2-11QY07167 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、119ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料はレノックス・ガストー症候群治療薬のグローバル市場について調査・分析したレポートです。種類別（ペランパネル、カンナビジオール、NRP-2945、塩酸フェンフルラミン、その他）市場規模、用途別（病院、診療所、家庭）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別レノックス・ガストー症候群治療薬の競争状況、市場シェア ・世界のレノックス・ガストー症候群治療薬市場：種類別市場規模 2015年-2020年（ペランパネル、カンナビジオール、NRP-2945、塩酸フェンフルラミン、その他） ・世界のレノックス・ガストー症候群治療薬市場：種類別市場規模予測 2021年-2026年（ペランパネル、カンナビジオール、NRP-2945、塩酸フェンフルラミン、その他） ・世界のレノックス・ガストー症候群治療薬市場：用途別市場規模 2015年-2020年（病院、診療所、家庭） ・世界のレノックス・ガストー症候群治療薬市場：用途別市場規模予測 2021年-2026年（病院、診療所、家庭） ・北米のレノックス・ガストー症候群治療薬市場分析：米国、カナダ ・ヨーロッパのレノックス・ガストー症候群治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのレノックス・ガストー症候群治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のレノックス・ガストー症候群治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのレノックス・ガストー症候群治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Eisai Co Ltd、GW Pharmaceuticals Plc、INSYS Therapeutics Inc、Zogenix Inc ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論

Market Analysis and Insights: Global Lennox-Gastaut Syndrome Drug Market
The global Lennox-Gastaut Syndrome Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Lennox-Gastaut Syndrome Drug Scope and Market Size
Lennox-Gastaut Syndrome Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Lennox-Gastaut Syndrome Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Lennox-Gastaut Syndrome Drug market is segmented into
Perampanel
Cannabidiol
NRP-2945
Fenfluramine Hydrochloride
Others

Segment by Application, the Lennox-Gastaut Syndrome Drug market is segmented into
Hospital
Clinic
Household

Regional and Country-level Analysis
The Lennox-Gastaut Syndrome Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Lennox-Gastaut Syndrome Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Lennox-Gastaut Syndrome Drug Market Share Analysis
Lennox-Gastaut Syndrome Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Lennox-Gastaut Syndrome Drug business, the date to enter into the Lennox-Gastaut Syndrome Drug market, Lennox-Gastaut Syndrome Drug product introduction, recent developments, etc.

The major vendors covered:
Eisai Co Ltd
GW Pharmaceuticals Plc
INSYS Therapeutics Inc
Zogenix Inc
…

レポート目次

---

1 Study Coverage
1.1 Lennox-Gastaut Syndrome Drug Product Introduction
1.2 Market Segments
1.3 Key Lennox-Gastaut Syndrome Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Lennox-Gastaut Syndrome Drug Market Size Growth Rate by Type
1.4.2 Perampanel
1.4.3 Cannabidiol
1.4.4 NRP-2945
1.4.5 Fenfluramine Hydrochloride
1.4.6 Others
1.5 Market by Application
1.5.1 Global Lennox-Gastaut Syndrome Drug Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Household
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Lennox-Gastaut Syndrome Drug Market Size, Estimates and Forecasts
2.1.1 Global Lennox-Gastaut Syndrome Drug Revenue 2015-2026
2.1.2 Global Lennox-Gastaut Syndrome Drug Sales 2015-2026
2.2 Global Lennox-Gastaut Syndrome Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Lennox-Gastaut Syndrome Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Lennox-Gastaut Syndrome Drug Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Lennox-Gastaut Syndrome Drug Competitor Landscape by Players
3.1 Lennox-Gastaut Syndrome Drug Sales by Manufacturers
3.1.1 Lennox-Gastaut Syndrome Drug Sales by Manufacturers (2015-2020)
3.1.2 Lennox-Gastaut Syndrome Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Lennox-Gastaut Syndrome Drug Revenue by Manufacturers
3.2.1 Lennox-Gastaut Syndrome Drug Revenue by Manufacturers (2015-2020)
3.2.2 Lennox-Gastaut Syndrome Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Lennox-Gastaut Syndrome Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Lennox-Gastaut Syndrome Drug Revenue in 2019
3.2.5 Global Lennox-Gastaut Syndrome Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Lennox-Gastaut Syndrome Drug Price by Manufacturers
3.4 Lennox-Gastaut Syndrome Drug Manufacturing Base Distribution, Product Types
3.4.1 Lennox-Gastaut Syndrome Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Lennox-Gastaut Syndrome Drug Product Type
3.4.3 Date of International Manufacturers Enter into Lennox-Gastaut Syndrome Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Lennox-Gastaut Syndrome Drug Market Size by Type (2015-2020)
4.1.1 Global Lennox-Gastaut Syndrome Drug Sales by Type (2015-2020)
4.1.2 Global Lennox-Gastaut Syndrome Drug Revenue by Type (2015-2020)
4.1.3 Lennox-Gastaut Syndrome Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Lennox-Gastaut Syndrome Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Lennox-Gastaut Syndrome Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Lennox-Gastaut Syndrome Drug Revenue Forecast by Type (2021-2026)
4.2.3 Lennox-Gastaut Syndrome Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Lennox-Gastaut Syndrome Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Lennox-Gastaut Syndrome Drug Market Size by Application (2015-2020)
5.1.1 Global Lennox-Gastaut Syndrome Drug Sales by Application (2015-2020)
5.1.2 Global Lennox-Gastaut Syndrome Drug Revenue by Application (2015-2020)
5.1.3 Lennox-Gastaut Syndrome Drug Price by Application (2015-2020)
5.2 Lennox-Gastaut Syndrome Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Lennox-Gastaut Syndrome Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Lennox-Gastaut Syndrome Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Lennox-Gastaut Syndrome Drug Price Forecast by Application (2021-2026)

6 North America
6.1 North America Lennox-Gastaut Syndrome Drug by Country
6.1.1 North America Lennox-Gastaut Syndrome Drug Sales by Country
6.1.2 North America Lennox-Gastaut Syndrome Drug Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Lennox-Gastaut Syndrome Drug Market Facts & Figures by Type
6.3 North America Lennox-Gastaut Syndrome Drug Market Facts & Figures by Application

7 Europe
7.1 Europe Lennox-Gastaut Syndrome Drug by Country
7.1.1 Europe Lennox-Gastaut Syndrome Drug Sales by Country
7.1.2 Europe Lennox-Gastaut Syndrome Drug Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Lennox-Gastaut Syndrome Drug Market Facts & Figures by Type
7.3 Europe Lennox-Gastaut Syndrome Drug Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Lennox-Gastaut Syndrome Drug by Region
8.1.1 Asia Pacific Lennox-Gastaut Syndrome Drug Sales by Region
8.1.2 Asia Pacific Lennox-Gastaut Syndrome Drug Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Lennox-Gastaut Syndrome Drug Market Facts & Figures by Type
8.3 Asia Pacific Lennox-Gastaut Syndrome Drug Market Facts & Figures by Application

9 Latin America
9.1 Latin America Lennox-Gastaut Syndrome Drug by Country
9.1.1 Latin America Lennox-Gastaut Syndrome Drug Sales by Country
9.1.2 Latin America Lennox-Gastaut Syndrome Drug Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Lennox-Gastaut Syndrome Drug Market Facts & Figures by Type
9.3 Central & South America Lennox-Gastaut Syndrome Drug Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Lennox-Gastaut Syndrome Drug by Country
10.1.1 Middle East and Africa Lennox-Gastaut Syndrome Drug Sales by Country
10.1.2 Middle East and Africa Lennox-Gastaut Syndrome Drug Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Lennox-Gastaut Syndrome Drug Market Facts & Figures by Type
10.3 Middle East and Africa Lennox-Gastaut Syndrome Drug Market Facts & Figures by Application

11 Company Profiles
11.1 Eisai Co Ltd
11.1.1 Eisai Co Ltd Corporation Information
11.1.2 Eisai Co Ltd Description and Business Overview
11.1.3 Eisai Co Ltd Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Eisai Co Ltd Lennox-Gastaut Syndrome Drug Products Offered
11.1.5 Eisai Co Ltd Related Developments
11.2 GW Pharmaceuticals Plc
11.2.1 GW Pharmaceuticals Plc Corporation Information
11.2.2 GW Pharmaceuticals Plc Description and Business Overview
11.2.3 GW Pharmaceuticals Plc Sales, Revenue and Gross Margin (2015-2020)
11.2.4 GW Pharmaceuticals Plc Lennox-Gastaut Syndrome Drug Products Offered
11.2.5 GW Pharmaceuticals Plc Related Developments
11.3 INSYS Therapeutics Inc
11.3.1 INSYS Therapeutics Inc Corporation Information
11.3.2 INSYS Therapeutics Inc Description and Business Overview
11.3.3 INSYS Therapeutics Inc Sales, Revenue and Gross Margin (2015-2020)
11.3.4 INSYS Therapeutics Inc Lennox-Gastaut Syndrome Drug Products Offered
11.3.5 INSYS Therapeutics Inc Related Developments
11.4 Zogenix Inc
11.4.1 Zogenix Inc Corporation Information
11.4.2 Zogenix Inc Description and Business Overview
11.4.3 Zogenix Inc Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Zogenix Inc Lennox-Gastaut Syndrome Drug Products Offered
11.4.5 Zogenix Inc Related Developments
11.1 Eisai Co Ltd
11.1.1 Eisai Co Ltd Corporation Information
11.1.2 Eisai Co Ltd Description and Business Overview
11.1.3 Eisai Co Ltd Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Eisai Co Ltd Lennox-Gastaut Syndrome Drug Products Offered
11.1.5 Eisai Co Ltd Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Lennox-Gastaut Syndrome Drug Market Estimates and Projections by Region
12.1.1 Global Lennox-Gastaut Syndrome Drug Sales Forecast by Regions 2021-2026
12.1.2 Global Lennox-Gastaut Syndrome Drug Revenue Forecast by Regions 2021-2026
12.2 North America Lennox-Gastaut Syndrome Drug Market Size Forecast (2021-2026)
12.2.1 North America: Lennox-Gastaut Syndrome Drug Sales Forecast (2021-2026)
12.2.2 North America: Lennox-Gastaut Syndrome Drug Revenue Forecast (2021-2026)
12.2.3 North America: Lennox-Gastaut Syndrome Drug Market Size Forecast by Country (2021-2026)
12.3 Europe Lennox-Gastaut Syndrome Drug Market Size Forecast (2021-2026)
12.3.1 Europe: Lennox-Gastaut Syndrome Drug Sales Forecast (2021-2026)
12.3.2 Europe: Lennox-Gastaut Syndrome Drug Revenue Forecast (2021-2026)
12.3.3 Europe: Lennox-Gastaut Syndrome Drug Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Lennox-Gastaut Syndrome Drug Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Lennox-Gastaut Syndrome Drug Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Lennox-Gastaut Syndrome Drug Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Lennox-Gastaut Syndrome Drug Market Size Forecast by Region (2021-2026)
12.5 Latin America Lennox-Gastaut Syndrome Drug Market Size Forecast (2021-2026)
12.5.1 Latin America: Lennox-Gastaut Syndrome Drug Sales Forecast (2021-2026)
12.5.2 Latin America: Lennox-Gastaut Syndrome Drug Revenue Forecast (2021-2026)
12.5.3 Latin America: Lennox-Gastaut Syndrome Drug Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Lennox-Gastaut Syndrome Drug Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Lennox-Gastaut Syndrome Drug Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Lennox-Gastaut Syndrome Drug Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Lennox-Gastaut Syndrome Drug Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Lennox-Gastaut Syndrome Drug Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Lennox-Gastaut Syndrome Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Lennox-Gastaut Syndrome Drug Market Segments
Table 2. Ranking of Global Top Lennox-Gastaut Syndrome Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Lennox-Gastaut Syndrome Drug Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Perampanel
Table 5. Major Manufacturers of Cannabidiol
Table 6. Major Manufacturers of NRP-2945
Table 7. Major Manufacturers of Fenfluramine Hydrochloride
Table 8. Major Manufacturers of Others
Table 9. Global Lennox-Gastaut Syndrome Drug Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global Lennox-Gastaut Syndrome Drug Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global Lennox-Gastaut Syndrome Drug Sales by Regions 2015-2020 (K Pcs)
Table 12. Global Lennox-Gastaut Syndrome Drug Sales Market Share by Regions (2015-2020)
Table 13. Global Lennox-Gastaut Syndrome Drug Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Lennox-Gastaut Syndrome Drug Sales by Manufacturers (2015-2020) (K Pcs)
Table 15. Global Lennox-Gastaut Syndrome Drug Sales Share by Manufacturers (2015-2020)
Table 16. Global Lennox-Gastaut Syndrome Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Lennox-Gastaut Syndrome Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lennox-Gastaut Syndrome Drug as of 2019)
Table 18. Lennox-Gastaut Syndrome Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Lennox-Gastaut Syndrome Drug Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Lennox-Gastaut Syndrome Drug Price (2015-2020) (USD/Pcs)
Table 21. Lennox-Gastaut Syndrome Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Lennox-Gastaut Syndrome Drug Product Type
Table 23. Date of International Manufacturers Enter into Lennox-Gastaut Syndrome Drug Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Lennox-Gastaut Syndrome Drug Sales by Type (2015-2020) (K Pcs)
Table 26. Global Lennox-Gastaut Syndrome Drug Sales Share by Type (2015-2020)
Table 27. Global Lennox-Gastaut Syndrome Drug Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Lennox-Gastaut Syndrome Drug Revenue Share by Type (2015-2020)
Table 29. Lennox-Gastaut Syndrome Drug Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 30. Global Lennox-Gastaut Syndrome Drug Sales by Application (2015-2020) (K Pcs)
Table 31. Global Lennox-Gastaut Syndrome Drug Sales Share by Application (2015-2020)
Table 32. North America Lennox-Gastaut Syndrome Drug Sales by Country (2015-2020) (K Pcs)
Table 33. North America Lennox-Gastaut Syndrome Drug Sales Market Share by Country (2015-2020)
Table 34. North America Lennox-Gastaut Syndrome Drug Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Lennox-Gastaut Syndrome Drug Revenue Market Share by Country (2015-2020)
Table 36. North America Lennox-Gastaut Syndrome Drug Sales by Type (2015-2020) (K Pcs)
Table 37. North America Lennox-Gastaut Syndrome Drug Sales Market Share by Type (2015-2020)
Table 38. North America Lennox-Gastaut Syndrome Drug Sales by Application (2015-2020) (K Pcs)
Table 39. North America Lennox-Gastaut Syndrome Drug Sales Market Share by Application (2015-2020)
Table 40. Europe Lennox-Gastaut Syndrome Drug Sales by Country (2015-2020) (K Pcs)
Table 41. Europe Lennox-Gastaut Syndrome Drug Sales Market Share by Country (2015-2020)
Table 42. Europe Lennox-Gastaut Syndrome Drug Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Lennox-Gastaut Syndrome Drug Revenue Market Share by Country (2015-2020)
Table 44. Europe Lennox-Gastaut Syndrome Drug Sales by Type (2015-2020) (K Pcs)
Table 45. Europe Lennox-Gastaut Syndrome Drug Sales Market Share by Type (2015-2020)
Table 46. Europe Lennox-Gastaut Syndrome Drug Sales by Application (2015-2020) (K Pcs)
Table 47. Europe Lennox-Gastaut Syndrome Drug Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Lennox-Gastaut Syndrome Drug Sales by Region (2015-2020) (K Pcs)
Table 49. Asia Pacific Lennox-Gastaut Syndrome Drug Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Lennox-Gastaut Syndrome Drug Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Lennox-Gastaut Syndrome Drug Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Lennox-Gastaut Syndrome Drug Sales by Type (2015-2020) (K Pcs)
Table 53. Asia Pacific Lennox-Gastaut Syndrome Drug Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Lennox-Gastaut Syndrome Drug Sales by Application (2015-2020) (K Pcs)
Table 55. Asia Pacific Lennox-Gastaut Syndrome Drug Sales Market Share by Application (2015-2020)
Table 56. Latin America Lennox-Gastaut Syndrome Drug Sales by Country (2015-2020) (K Pcs)
Table 57. Latin America Lennox-Gastaut Syndrome Drug Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Lennox-Gastaut Syndrome Drug Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Lennox-Gastaut Syndrome Drug Revenue Market Share by Country (2015-2020)
Table 60. Latin America Lennox-Gastaut Syndrome Drug Sales by Type (2015-2020) (K Pcs)
Table 61. Latin America Lennox-Gastaut Syndrome Drug Sales Market Share by Type (2015-2020)
Table 62. Latin America Lennox-Gastaut Syndrome Drug Sales by Application (2015-2020) (K Pcs)
Table 63. Latin America Lennox-Gastaut Syndrome Drug Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Lennox-Gastaut Syndrome Drug Sales by Country (2015-2020) (K Pcs)
Table 65. Middle East and Africa Lennox-Gastaut Syndrome Drug Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Lennox-Gastaut Syndrome Drug Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Lennox-Gastaut Syndrome Drug Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Lennox-Gastaut Syndrome Drug Sales by Type (2015-2020) (K Pcs)
Table 69. Middle East and Africa Lennox-Gastaut Syndrome Drug Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Lennox-Gastaut Syndrome Drug Sales by Application (2015-2020) (K Pcs)
Table 71. Middle East and Africa Lennox-Gastaut Syndrome Drug Sales Market Share by Application (2015-2020)
Table 72. Eisai Co Ltd Corporation Information
Table 73. Eisai Co Ltd Description and Major Businesses
Table 74. Eisai Co Ltd Lennox-Gastaut Syndrome Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 75. Eisai Co Ltd Product
Table 76. Eisai Co Ltd Recent Development
Table 77. GW Pharmaceuticals Plc Corporation Information
Table 78. GW Pharmaceuticals Plc Description and Major Businesses
Table 79. GW Pharmaceuticals Plc Lennox-Gastaut Syndrome Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. GW Pharmaceuticals Plc Product
Table 81. GW Pharmaceuticals Plc Recent Development
Table 82. INSYS Therapeutics Inc Corporation Information
Table 83. INSYS Therapeutics Inc Description and Major Businesses
Table 84. INSYS Therapeutics Inc Lennox-Gastaut Syndrome Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. INSYS Therapeutics Inc Product
Table 86. INSYS Therapeutics Inc Recent Development
Table 87. Zogenix Inc Corporation Information
Table 88. Zogenix Inc Description and Major Businesses
Table 89. Zogenix Inc Lennox-Gastaut Syndrome Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. Zogenix Inc Product
Table 91. Zogenix Inc Recent Development
Table 92. Global Lennox-Gastaut Syndrome Drug Sales Forecast by Regions (2021-2026) (K Pcs)
Table 93. Global Lennox-Gastaut Syndrome Drug Sales Market Share Forecast by Regions (2021-2026)
Table 94. Global Lennox-Gastaut Syndrome Drug Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 95. Global Lennox-Gastaut Syndrome Drug Revenue Market Share Forecast by Regions (2021-2026)
Table 96. North America: Lennox-Gastaut Syndrome Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 97. North America: Lennox-Gastaut Syndrome Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 98. Europe: Lennox-Gastaut Syndrome Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 99. Europe: Lennox-Gastaut Syndrome Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 100. Asia Pacific: Lennox-Gastaut Syndrome Drug Sales Forecast by Region (2021-2026) (K Pcs)
Table 101. Asia Pacific: Lennox-Gastaut Syndrome Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 102. Latin America: Lennox-Gastaut Syndrome Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 103. Latin America: Lennox-Gastaut Syndrome Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 104. Middle East and Africa: Lennox-Gastaut Syndrome Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 105. Middle East and Africa: Lennox-Gastaut Syndrome Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 106. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 107. Key Challenges
Table 108. Market Risks
Table 109. Main Points Interviewed from Key Lennox-Gastaut Syndrome Drug Players
Table 110. Lennox-Gastaut Syndrome Drug Customers List
Table 111. Lennox-Gastaut Syndrome Drug Distributors List
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Lennox-Gastaut Syndrome Drug Product Picture
Figure 2. Global Lennox-Gastaut Syndrome Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Perampanel Product Picture
Figure 4. Cannabidiol Product Picture
Figure 5. NRP-2945 Product Picture
Figure 6. Fenfluramine Hydrochloride Product Picture
Figure 7. Others Product Picture
Figure 8. Global Lennox-Gastaut Syndrome Drug Sales Market Share by Application in 2020 & 2026
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Household
Figure 12. Lennox-Gastaut Syndrome Drug Report Years Considered
Figure 13. Global Lennox-Gastaut Syndrome Drug Market Size 2015-2026 (US$ Million)
Figure 14. Global Lennox-Gastaut Syndrome Drug Sales 2015-2026 (K Pcs)
Figure 15. Global Lennox-Gastaut Syndrome Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Lennox-Gastaut Syndrome Drug Sales Market Share by Region (2015-2020)
Figure 17. Global Lennox-Gastaut Syndrome Drug Sales Market Share by Region in 2019
Figure 18. Global Lennox-Gastaut Syndrome Drug Revenue Market Share by Region (2015-2020)
Figure 19. Global Lennox-Gastaut Syndrome Drug Revenue Market Share by Region in 2019
Figure 20. Global Lennox-Gastaut Syndrome Drug Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Lennox-Gastaut Syndrome Drug Revenue in 2019
Figure 22. Lennox-Gastaut Syndrome Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Lennox-Gastaut Syndrome Drug Sales Market Share by Type (2015-2020)
Figure 24. Global Lennox-Gastaut Syndrome Drug Sales Market Share by Type in 2019
Figure 25. Global Lennox-Gastaut Syndrome Drug Revenue Market Share by Type (2015-2020)
Figure 26. Global Lennox-Gastaut Syndrome Drug Revenue Market Share by Type in 2019
Figure 27. Global Lennox-Gastaut Syndrome Drug Market Share by Price Range (2015-2020)
Figure 28. Global Lennox-Gastaut Syndrome Drug Sales Market Share by Application (2015-2020)
Figure 29. Global Lennox-Gastaut Syndrome Drug Sales Market Share by Application in 2019
Figure 30. Global Lennox-Gastaut Syndrome Drug Revenue Market Share by Application (2015-2020)
Figure 31. Global Lennox-Gastaut Syndrome Drug Revenue Market Share by Application in 2019
Figure 32. North America Lennox-Gastaut Syndrome Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 33. North America Lennox-Gastaut Syndrome Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Lennox-Gastaut Syndrome Drug Sales Market Share by Country in 2019
Figure 35. North America Lennox-Gastaut Syndrome Drug Revenue Market Share by Country in 2019
Figure 36. U.S. Lennox-Gastaut Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 37. U.S. Lennox-Gastaut Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Lennox-Gastaut Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. Canada Lennox-Gastaut Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Lennox-Gastaut Syndrome Drug Market Share by Type in 2019
Figure 41. North America Lennox-Gastaut Syndrome Drug Market Share by Application in 2019
Figure 42. Europe Lennox-Gastaut Syndrome Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 43. Europe Lennox-Gastaut Syndrome Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Lennox-Gastaut Syndrome Drug Sales Market Share by Country in 2019
Figure 45. Europe Lennox-Gastaut Syndrome Drug Revenue Market Share by Country in 2019
Figure 46. Germany Lennox-Gastaut Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 47. Germany Lennox-Gastaut Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Lennox-Gastaut Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. France Lennox-Gastaut Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Lennox-Gastaut Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. U.K. Lennox-Gastaut Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Lennox-Gastaut Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. Italy Lennox-Gastaut Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Lennox-Gastaut Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Russia Lennox-Gastaut Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Lennox-Gastaut Syndrome Drug Market Share by Type in 2019
Figure 57. Europe Lennox-Gastaut Syndrome Drug Market Share by Application in 2019
Figure 58. Asia Pacific Lennox-Gastaut Syndrome Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 59. Asia Pacific Lennox-Gastaut Syndrome Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Lennox-Gastaut Syndrome Drug Sales Market Share by Region in 2019
Figure 61. Asia Pacific Lennox-Gastaut Syndrome Drug Revenue Market Share by Region in 2019
Figure 62. China Lennox-Gastaut Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 63. China Lennox-Gastaut Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Lennox-Gastaut Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. Japan Lennox-Gastaut Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Lennox-Gastaut Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. South Korea Lennox-Gastaut Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Lennox-Gastaut Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. India Lennox-Gastaut Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Lennox-Gastaut Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. Australia Lennox-Gastaut Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Lennox-Gastaut Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Taiwan Lennox-Gastaut Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Lennox-Gastaut Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Indonesia Lennox-Gastaut Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Lennox-Gastaut Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Thailand Lennox-Gastaut Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Lennox-Gastaut Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Malaysia Lennox-Gastaut Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Lennox-Gastaut Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Philippines Lennox-Gastaut Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Lennox-Gastaut Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Vietnam Lennox-Gastaut Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Lennox-Gastaut Syndrome Drug Market Share by Type in 2019
Figure 85. Asia Pacific Lennox-Gastaut Syndrome Drug Market Share by Application in 2019
Figure 86. Latin America Lennox-Gastaut Syndrome Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 87. Latin America Lennox-Gastaut Syndrome Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Lennox-Gastaut Syndrome Drug Sales Market Share by Country in 2019
Figure 89. Latin America Lennox-Gastaut Syndrome Drug Revenue Market Share by Country in 2019
Figure 90. Mexico Lennox-Gastaut Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 91. Mexico Lennox-Gastaut Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Lennox-Gastaut Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Brazil Lennox-Gastaut Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Lennox-Gastaut Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Argentina Lennox-Gastaut Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Lennox-Gastaut Syndrome Drug Market Share by Type in 2019
Figure 97. Latin America Lennox-Gastaut Syndrome Drug Market Share by Application in 2019
Figure 98. Middle East and Africa Lennox-Gastaut Syndrome Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 99. Middle East and Africa Lennox-Gastaut Syndrome Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Lennox-Gastaut Syndrome Drug Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Lennox-Gastaut Syndrome Drug Revenue Market Share by Country in 2019
Figure 102. Turkey Lennox-Gastaut Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 103. Turkey Lennox-Gastaut Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Lennox-Gastaut Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Saudi Arabia Lennox-Gastaut Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Lennox-Gastaut Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. U.A.E Lennox-Gastaut Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Lennox-Gastaut Syndrome Drug Market Share by Type in 2019
Figure 109. Middle East and Africa Lennox-Gastaut Syndrome Drug Market Share by Application in 2019
Figure 110. North America Lennox-Gastaut Syndrome Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 111. North America Lennox-Gastaut Syndrome Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Europe Lennox-Gastaut Syndrome Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. Europe Lennox-Gastaut Syndrome Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Asia Pacific Lennox-Gastaut Syndrome Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Asia Pacific Lennox-Gastaut Syndrome Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Latin America Lennox-Gastaut Syndrome Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Latin America Lennox-Gastaut Syndrome Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Middle East and Africa Lennox-Gastaut Syndrome Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Middle East and Africa Lennox-Gastaut Syndrome Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Porter's Five Forces Analysis
Figure 121. Channels of Distribution
Figure 122. Distributors Profiles
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed

---